Sulit, Irsih U.
HRN: 23-63-21 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/28/2023
CEFUROXIME 500MG (TAB)
09/28/2023
10/04/2023
ORAL
500mg
BID
Perineal Laceration With Repair
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes